News
2022.07.05
On July 5, Dx&Vx announced its entry into the disease prevention and control market in preparation for the endemic era by introducing Philips UV-C disinfection air cleaner in June. The company is in the process of being emerging as a provider of total solutions, from diagnosis to prevention, to deal with new strains of infectious diseases. It has been participating in a consortium for the development of advanced vaccine platforms based on genome analysis and developing in vitro diagnostic products. Its entry into the disease prevention market is known to be a new business being pursued as part of its efforts to achieve this vision. Philips UV-C disinfector is a stand-type air purifier known for its advanced technology and safety that has been developed by Philips, which has specialized in sterilization and disinfection for over 35 years. It uses an airflow method in which the device sucks in air to disinfect it before discharging it, and then it quickly destroys the DNA and RNA of viruses, bacteria, and fungi in the air using UV-C lamps. Thus, it is harmless to the human body. It also has the clinical results that the device killed over 99% of the coronavirus, SARS-CoV-2, jointly conducted with Boston University. The report was published in the international scientific journal, Nature, in 2020. Also, according to an evaluation by the Korea Testing Laboratory, the reduction rate for viruses and bacteria suspended in the air was 99.4% and 99.7%, respectively. Since the device sterilizes the air with UV-C (ultraviolet rays), without the use of disinfectants or chemicals, there are no toxic residues. The product has also been confirmed of its excellence safety in relation to generating ozone, which has been noted as a potential risk factor when it comes to air disinfection systems. The product has been verified of its ozone-related safety, conforming to European standards, which are five times stricter than Korea’s standards. It has been installed in national and public schools in Germany since 2021, operating as a disinfection solution. With the Philips air disinfection system becoming known as a safe and eco-friendly means of preventing the spread of infectious diseases indoors, it has recently been installed in classrooms in New Zealand, and it also has recorded considerable sales in Japan. The UV-C lamp, which is the key element in the sterilization and disinfection process, lasts for up to 9,000 hours. So it is highly cost-effective, as there is no need for frequent replacement. Plus, the stand-type UV-C air cleaner from Philips has proven excellent performance, sterilizing 95% of the indoor air within one hour. Therefore, it is expected to become high in demand at hospitals, nursing homes, pharmacies, and research labs that require infection prevention or air disinfection. A representative from Dx&Vx said, “As there is a greater importance being placed on day-to-day practices for disease prevention and control after the pandemic, our primary target market will include hospitals, clinics, research labs, and schools, but the demand is expected to gradually expand across all areas. […] Starting with the introduction of the Philips UV-C air cleaner, we plan to lead the market by launching a variety of disease prevention products such as personal hygiene and living sanitation products in the second half of the year.” Meanwhile, Dx&Vx recorded a turnaround in quarterly operating profits for the first time in three years by achieving overall business improvement since the new management took office. The recently established healthcare solution business team is responsible for supplying various bio and healthcare products and merchandise to domestic and overseas markets. Source: The Asia Business Daily